- Original Article
-
The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease
-
Cheng Han Ng, Kai En Chan, Yip Han Chin, Rebecca Wenling Zeng, Pei Chen Tsai, Wen Hui Lim, Darren Jun Hao Tan, Chin Meng Khoo, Lay Hoon Goh, Zheng Jye Ling, Anand Kulkarni, Lung-Yi Loey Mak, Daniel Q Huang, Mark Chan, Nicholas WS Chew, Mohammad Shadab Siddiqui, Arun J. Sanyal, Mark Muthiah
-
Clin Mol Hepatol. 2022;28(3):565-574. Published online May 19, 2022
-
-
-
Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults
-
Seogsong Jeong, Yun Hwan Oh, Seulggie Choi, Jooyoung Chang, Sung Min Kim, Joung Sik Son, Gyeongsil Lee, Joseph C Ahn, Dong Hyeon Lee, Bo Kyung Koo, Won Kim, Sang Min Park
-
Clin Mol Hepatol. 2022;28(3):510-521. Published online March 17, 2022
-
-
- Letter to the Editor
-
Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs
-
Saori Takamura, Yuichi Teraki, Eri Katayama, Takumi Kawaguchi, Machiko Kawaguchi, Dan Nakano, Tsubasa Tsutsumi, Sumiko Nagoshi, Takekuni Nakama, Takuji Torimura
-
Clin Mol Hepatol. 2022;28(2):269-272. Published online February 15, 2022
-
-
|